Valbiotis SA (FR:ALVAL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Valbiotis SA, a French scientific research company specializing in dietary supplements for metabolic disorders, has a share capital composed of 15,794,596 shares with voting rights listed on Euronext Growth Paris. The company is committed to revolutionizing health products by using marine and terrestrial plants, aiming for international licensing agreements while managing French marketing internally. Valbiotis benefits from significant EU financial support and holds the “Innovative Company” label, making it an attractive option for investors.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.